[1] |
Solh M. Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia[J]. World J Stem Cells, 2014, 6(4):371-379. doi: 10.4252/wjsc.v6.i4.371
|
[2] |
Eapen M, Wagner JE. Transplant outcomes in acute leukemia.I.[J]. Semin Hematol, 2010, 47(1):46-50. doi: 10.1053/j.seminhematol.2009.10.007
|
[3] |
Piñana JL, Sanz J, Esquirol A, et al. Umbilical cord blood transplantation in adults with advanced hodgkin's disease:high incidence of post-transplant lymphoproliferative disease[J]. Eur J Haematol, 2015, DOI:10.1111/ejh.12557[Epub ahead of print].
|
[4] |
Tucunduva L, Ruggeri A, Sanz G, et al. Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia:a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation[J]. Bone Marrow Transplant, 2014, 49(7):887-894. doi: 10.1038/bmt.2014.72
|
[5] |
Marks DI, Woo KA, Zhong X, et al. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second completeremission:a comparison with allografts from adult unrelated donors[J]. Haematologica, 2014, 99(2):322-328. doi: 10.3324/haematol.2013.094193
|
[6] |
Ruqqeri A, Labopin M, Sanz G, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantationin adults with acute leukemia[J]. Leukemia, 2015, 29(9):1891-1900. doi: 10.1038/leu.2015.98
|
[7] |
Robin M, Ruggeri A, Labopin M, et al. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen:a collaborative study from Eurocord (Cord Blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party[J]. Biol Blood Marrow Transplant, 2015, 21(3):489-495. doi: 10.1016/j.bbmt.2014.11.675
|
[8] |
Sanz J, Boluda JC, Martin C, et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen[J].Bone Marrow Transplant, 2012, 47(10):1287-1293. doi: 10.1038/bmt.2012.13
|
[9] |
Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia[J]. Blood, 2013, 121(5):752-758. doi: 10.1182/blood-2012-08-449108
|
[10] |
Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors[J]. Transplantation, 1974, 18(4):295-304. doi: 10.1097/00007890-197410000-00001
|
[11] |
Fernandes JF, Rocha V, Labopin M, et al. Transplantation in patients with SCID:mismatched related stem cells or unrelated cord blood?[J]. Blood, 2012, 119(12):2949-2955. doi: 10.1182/blood-2011-06-363572
|
[12] |
Danby R, Rocha V. Improving engraftment and immune reconstitution in umbilical cord blood transplantation[J]. Front Immunol, 2014, 5:68. http://cn.bing.com/academic/profile?id=2112888327&encoded=0&v=paper_preview&mkt=zh-cn
|
[13] |
Delaney C, Heimfeld S, Brashem-Stein C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution[J]. Nat Med, 2010, 16(2):232-236. doi: 10.1038/nm.2080
|
[14] |
de Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture[J]. N Engl J Med, 2012, 367(24):2305-2315. doi: 10.1056/NEJMoa1207285
|
[15] |
Zheng C, Zhu X, Tang B, et al. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia[J].Ann Hematol, 2015, 94(3):473-480. doi: 10.1007/s00277-014-2213-y
|
[16] |
Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia:a retrospective analysis[J]. Lancet Oncol, 2010, 11(7):653-660. doi: 10.1016/S1470-2045(10)70127-3
|
[17] |
Zheng C, Tang B, Tong J, et al. Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia[J]. Ann Hematol, 2013, 92(12):1665-1673. doi: 10.1007/s00277-013-1820-3
|